MNKD Stock Price 1D 5D 1M 6M YTD 1Y 5Y 10Y MAX Basic Advanced +15.56% MannKind Corporation price and volume Combination chart with 2 data series. Chart represents MannKind Corporation price and volume over 1Y period The chart has 2 X axes displaying Time, and Time. The chart has 2 Y ...
Stock Detail•Compare Perf.•Short Interest•Financials•Traffic•Options•Latest Filings•Add to Portfolio•Set Alert Draw Ideas Intraday Daily Weekly Monthly MNKD - Stock Price Chart DateActionAnalystRating ChangePrice Target Change
Price to Book (P/B)N/A Price to Sales (P/S)6.29 Price to Cash Flow (P/CF)45.00 P/FCF Ratio53.10 Enterprise Value/Market Cap1.12 Enterprise Value/Revenue7.26 Enterprise Value/Gross Profit13.85 Enterprise Value/Ebitda35.25 Forecast 1Y Price Target$10.00 Price Target Upside65.84% Upside Rating...
Average price target from 7 ratings: $10.00 Average score: Sell Under Hold Over BuyFull Ratings StockGrader Rating: 48.3 SELL Downgraded from HOLD on 11/15/24 The Company Scores Poorly in MarketGrader's Growth at a Reasonable Price Analysis Sentiment:3.78/10 NEGATIVEFull Analysis Open $5.2...
Analyst Price Forecast Suggests 44.32% Upside As of December 2, 2024, the average one-yearprice targetfor MannKind is $9.08/share. The forecasts range from a low of $7.07 to a high of $12.60. The average price target represents an increase of 44.32% from its latest reported closing price...
In 2024, we transformed our balance sheet, paying down debt of 236 million across three instruments, resulting in a remaining debt balance of just $36 million related to our senior convertible notes. We used a combination of cash and stock to avoid potential dilution of 12 million shares of ...
Dividend Stock News REITs Dividend Ideas Dividend Strategy Dividend Quick Picks Editors' Picks Analysis by Sector Energy Communication Services Real Estate Consumer Staples Tech Basic Materials Healthcare Consumer Utilities Financials Industrials Stock Comparison Tools FAANG Stocks Gold ETFs Cas...
Cooper Co has an analyst consensus of Moderate Buy, with a price target consensus of $347.50, representing a 12.6% upside. In a report issued on August 29, KeyBanc also downgraded the stock to Hold. TipRanks has tracked 36,000 company insiders and found that a few o...
MannKind started at outperform with $3 stock price target at SVB Leerink Mar. 4, 2019 at 8:56 a.m. ETby Tomi Kilgore BiotechWhy Investors Should Cash Out Of This Soaring Biotech Stock Feb. 25, 2019 at 12:53 p.m. ETby Barron's ...
MannKind started at outperform with $3 stock price target at SVB Leerink Mar. 4, 2019 at 8:56 a.m. ETby Tomi Kilgore BiotechWhy Investors Should Cash Out Of This Soaring Biotech Stock Feb. 25, 2019 at 12:53 p.m. ETby Barron's ...